unknown
Stage
About
Inhalis Therapeutics develops inhaled drug formulations and delivery technologies to treat idiopathic pulmonary fibrosis and other serious respiratory diseases. The company is based in Lugano, Switzerland.
Explore Inhalis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.